Hyperinsulinemia and hypertriglyceridemia, a vicious cycle with atherogenic potential

Area of Science:

• Metabolic Syndrome
• Cardiovascular Disease Research
• Endocrinology

Background:

• Hypertriglyceridemia is a risk factor for cardiovascular disease.
• The relationship between hypertriglyceridemia and insulin resistance is complex.
• Obesity and diabetes are commonly associated with insulin resistance.

Purpose of the Study:

• To review and integrate experimental evidence.
• To elucidate a potential vicious cycle linking hypertriglyceridemia and insulin resistance.
• To explore the implications for very-low-density lipoprotein (VLDL) metabolism and atherogenesis.

Main Methods:

• Literature review and integration of experimental findings.
• Analysis of the feedback loop between triglyceride levels and insulin sensitivity.
• Examination of VLDL-triglyceride production and removal dynamics.

Main Results:

• Hypertriglyceridemia can induce insulin resistance independently of obesity or diabetes.
• Insulin resistance may drive hyperinsulinemia in response to glucose.
• Hyperinsulinemia can stimulate VLDL-triglyceride production, exacerbating hypertriglyceridemia.

Conclusions:

• A vicious cycle exists where hypertriglyceridemia promotes insulin resistance, which in turn increases VLDL-triglyceride production.
• This cycle accelerates VLDL turnover and may increase atherogenic VLDL-remnants.
• Understanding this cycle is crucial for managing metabolic and cardiovascular risks.